| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL RESEARCH |
Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
Correspondence: Dr. Sushrut S. Waikar, Brigham and Women's Hospital, MRB-4, 75 Francis Street, Boston, MA 02115. Phone: 617-732-8474; Fax: 617-732-6392; E-mail: swaikar{at}partners.org
Received for publication July 2, 2008. Accepted for publication October 2, 2008.
Acute kidney injury (AKI) is a common and devastating medical condition, but no widely accepted definition exists. A recent classification system by the Acute Dialysis Quality Initiative (RIFLE) defines AKI largely by percentage increases in serum creatinine (SCr) over baseline. The Acute Kidney Injury Network defines the first stage by either an absolute or a percentage increase in SCr. To examine the implications of various definitions, we solved differential equations on the basis of mass balance principles. We simulated creatinine kinetics after AKI in the setting of normal baseline kidney function and stages 2, 3, and 4 chronic kidney disease (CKD). The percentage changes in SCr after severe AKI are highly dependent on baseline kidney function. Twenty-four hours after a 90% reduction in creatinine clearance, the rise in SCr was 246% with normal baseline kidney function, 174% in stage 2 CKD, 92% in stage 3 CKD, and only 47% in stage 4 CKD. By contrast, the absolute increase was nearly identical (1.8 to 2.0 mg/dl) across the spectrum of baseline kidney function. Time to reach a 50% increase in SCr was directly related to baseline kidney function: From 4 h (normal baseline) up to 27 h for stage 4 CKD. By contrast, the time to reach a 0.5-mg/dl increase in SCr was virtually identical after moderate to severe AKI (>50% reduction in creatinine clearance). We propose an alternative definition of AKI that incorporates absolute changes in SCr over a 24- to 48-h time period.
Related Article
J. Am. Soc. Nephrol. 2009 20: A12.
This article has been cited by other articles:
![]() |
P. J. Nelson and L. Cantley GSK3{beta} Plays Dirty in Acute Kidney Injury J. Am. Soc. Nephrol., February 1, 2010; 21(2): 199 - 200. [Full Text] [PDF] |
||||
![]() |
A. J P Lewington and A. Sayed Acute kidney injury: how do we define it? Ann Clin Biochem, January 1, 2010; 47(1): 4 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Endre and J. W. Pickering Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI) Nephrol. Dial. Transplant., January 1, 2010; 25(1): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Waikar, R. A. Betensky, and J. V. Bonventre Creatinine as the gold standard for kidney injury biomarker studies? Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3263 - 3265. [Full Text] [PDF] |
||||
![]() |
J. W. Pickering, C. M. Frampton, and Z. H. Endre Evaluation of Trial Outcomes in Acute Kidney Injury by Creatinine Modeling Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1705 - 1715. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673